Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CD55 Antikörper

CD55 Reaktivität: Human WB, IHC, ELISA Wirt: Maus Chimeric LU30 unconjugated Recombinant Antibody
Produktnummer ABIN5668198
  • Target Alle CD55 Antikörper anzeigen
    CD55 (Complement Decay-Accelerating Factor (CD55))
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    • 123
    • 32
    • 7
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    Human
    Wirt
    • 86
    • 64
    • 6
    • 5
    • 2
    • 1
    • 1
    Maus
    Klonalität
    • 100
    • 64
    • 1
    Chimeric
    Konjugat
    • 78
    • 16
    • 14
    • 11
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CD55 Antikörper ist unkonjugiert
    Applikation
    • 92
    • 89
    • 43
    • 33
    • 28
    • 24
    • 17
    • 15
    • 14
    • 14
    • 8
    • 4
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Verwendungszweck
    Anti-CD55 [LU30], Mouse IgG1, lambda
    Spezifität
    The antibody binds to CD55 with a Kd of 13 nM.
    Produktmerkmale
    Human
    Aufreinigung
    Protein A affinity purified
    Immunogen
    Human CD55.
    Klon
    LU30
    Isotyp
    IgG1 lambda
    Top Product
    Discover our top product CD55 Primärantikörper
  • Applikationshinweise
    The antibody binds specifically to CD55, a glycophosphatidylinositol-anchored protein which acts together with CD46 and CD59 to protect cells from complement-mediated cell lysis. The antigen recognises C4b, C3 and C3b complement components, and, by blocking their catalytic activity, inhibits the formation of the membrane attack complex. CD55 is overexpressed in many tumour cell lines, thereby inhibiting complement-mediated cell lysis and increases tumour resistance to immune attacks.
    Kommentare

    This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1 mg/mL
    Buffer
    PBS with 0.02 % Proclin 300.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target
    CD55 (Complement Decay-Accelerating Factor (CD55))
    Andere Bezeichnung
    CD55 (CD55 Produkte)
    Hintergrund
    DAF, Complement decay-accelerating factor
    UniProt
    P08174
    Pathways
    Komplementsystem, Regulation of Leukocyte Mediated Immunity
Sie sind hier:
Kundenservice